Sharon Henderson

Amid declining sales and a falling stock price, USANA brings back former CEO Kevin Guest to steer the company, replacing Jim Brown after a tough three-year tenure.

The dessert franchise touts record sales and coast-to-coast expansion, signaling a froyo comeback. But a closer look reveals a complex story of high hopes and financial risks.

The market research tech firm secures a strategic investment from TA Associates to scale its AI-powered platform and redefine data quality standards.

Retail's next frontier is here. AI agents are moving beyond chatbots to autonomously discover, select, and purchase goods on your behalf. Here's what's coming.

A strategic bet on ethnic grocery-anchored retail pays off as Arc Capital Partners exits a revitalized Torrance center in a $108.5 million blockbuster deal.

Earable Neuroscience partners with Tonino Lamborghini for a $1,999 brainband and joins the NSF's network, betting big on the new market of luxury cognitive tech.

Online education giant Stride, Inc. is embroiled in a legal battle over claims of inflated enrollment, systemic failures, and a 54% stock crash.

Fintech leader MeridianLink hires former Genesys and Permira exec Raj Patel as CTO, signaling a major push into AI-driven digital lending platforms.

Optable's new Planner Agent uses AI to slash ad planning time, but its bet on open standards could reshape the entire programmatic ecosystem.

The fresh food packaging market is set to soar, but can it balance consumer demands for sustainability, safety, and convenience with the high costs of innovation?

Future FinTech and quant firm S1Quant partner to build a compliant bridge for institutional investors into the volatile world of cryptocurrency assets.

South Korea's Curogen secures major national funding and targets global partners at the JP Morgan conference, advancing novel therapies for IBD and HS.

Fresh from a financial turnaround, Varvee Global expands its non-denim fabric capacity, signaling a major pivot from its denim legacy to capture India's textile boom.

A major new partnership is funding research to develop vital diagnostic tests for FTD, aiming to end years-long diagnostic delays for families.

Entertainment giant Banijay divests its majority stake in bet-at-home to fund a landmark merger with Tipico, reshaping its gaming strategy and the market.

Nexxen doubles down on shareholder returns with a new $40M buyback, signaling deep confidence amid market volatility and a strategic push into CTV.

As Wesdome Gold Mines targets mid-tier status, the appointment of financial expert Faheem Tejani signals a strategic move to bolster financial oversight.

Veracyte prepares for the J.P. Morgan conference, where it will showcase its AI and genomic strategy amid strong financials and a competitive market.

Alico pivots from its 125-year citrus legacy to land development, and its CEO is set to face investors with a bold new plan for its 50,000 acres.

Greenwich LifeSciences execs extend their stock lock-up to 6 years, signaling massive confidence in their breast cancer drug showing an 80% recurrence drop.